Hims' obesity drug business may get boost as employers drop coverage - Reuters
Hims' obesity drug business may get boost as employers drop coverage Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOTDFjWlB1UXFrd0JCNWZPZmZDaWpHNVlLZDBFSDA2MXpNOFJUS1Bhdll3LU91QmpjdUFPd09UWURpQ0t4Y2duOUk3NkNrZi1MLUUwYzFzSDNRU1NZV1pSREhkS1p1bkptVy0zcTBNbjR0RnJZTzRGWm5ITkxKUXZsWHBjZ05aa2k4eXI3UHVfUWVwVW83NmxQc2RMMGdpb3FWMzVNVHhPOGpid3hmWlRiS1FhMUlobHlu?oc=5" target="_blank">Hims' obesity drug business may get boost as employers drop coverage</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMLilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMAs Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters
As Hims prepares for peptides launch, Wall Street cautious on prospects this year Reuters
August 12, 2026 at 06:34 PMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMIce cream makers bet consumers still want treats, just healthier ones - Reuters
Ice cream makers bet consumers still want treats, just healthier ones Reuters
August 13, 2026 at 06:27 AMHumana agrees not to reference Teva's Israel ties at US drug trial - Reuters
Humana agrees not to reference Teva's Israel ties at US drug trial Reuters
August 13, 2026 at 03:33 PM